
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
The podcast will cover a description of powdered lipids, how they are manufactured, why and when to use them, the benefits of ABITEC’s powdered lipids and claims that can be made when using powdered lipids.






